Search

everythinglearnresearchcommunity

for

Search:↓

CGF injections may safely and effectively promote hair growth in androgenetic alopecia patients.

Secukinumab treatment may cause HBV reactivation and hair discoloration.

Small Botox dose effectively treats hair loss in Chinese men.

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

Granulocyte colony stimulating factor helps heal wounds without scars.

Patients with central centrifugal cicatricial alopecia may have a higher risk of breast and colorectal cancer.

CTCL patients can safely continue treatment during COVID-19 with proper safety measures.

CG2001 is safe and well-tolerated for treating hair loss in men.

Apple-derived procyanidin B-2 can safely promote hair growth in men.

PBM helps improve cell survival in 3D tissue engineering.

Betamethasone valerate foam is more effective and safe for treating mild-to-moderate alopecia areata than betamethasone dipropionate lotion.

Radiation therapy with a higher dose for the brain improves survival in cerebellar medulloblastoma.

RF-mesotherapy with bicalutamide may be a promising new treatment for hair loss.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

Allergens might contribute to CCCA, so avoiding them could help manage the condition.

Vitamin B complex improves plastic and cosmetic surgery outcomes by enhancing tissue repair and reducing inflammation.

The Virtual Magic Wand program successfully trained dermatologists in innovation, with most feeling capable of leading innovation teams and many starting companies.

The research created a detailed map of skin cells, showing that certain cells in basal cell carcinoma may come from hair follicles and could help the cancer grow.

DNCB is more effective than betamethasone for hair regrowth but has more side effects.

Adipose-derived stem cell-conditioned medium can reduce melanoma cell growth and spread.

CG2001 is safe, well-tolerated, and a promising treatment for hair loss with fewer side effects.

PCFCL may have unrecognized subtypes and needs more research.

CG2001 is safe and well-tolerated for treating hair loss, with fewer side effects than oral finasteride.

A patient developed a blister at the injection site after hepatitis C treatment.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

Berberine may reduce prostate enlargement by blocking inflammation.

High doses of cyproterone acetate are linked to an increased risk of developing meningioma.

The COVID-19 pandemic has led to more severe cases of Leprosy due to delayed medical care.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.